Personal information

Germany

Activities

Employment (2)

Universitätsklinikum Tübingen Interfakultäres Institut für Zellbiologie: Tubingen, Baden-Württemberg, DE

2015 to present (Abteilung Immunologie)
Employment
Source: Self-asserted source
Sebastian Haen

Universitätsklinikum Tübingen Medizinische Universitätsklinik: Tubingen, Baden-Württemberg, DE

2007 to present (Abteilung II für Onkologie, Hämatologie, Immunologie, Rheumatologie und Pulmologie)
Employment
Source: Self-asserted source
Sebastian Haen

Works (18)

Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment Protocols.

2017-02 | Journal article
Contributors: Löffler MW; Schuster H; Zeck A; Quilitz N; Weinreich J; Tolios A; Haen SP; Horvath P; Löb S; Rammensee HG et al.
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies.

2017-02 | Journal article
Contributors: Haen SP; Eyb V; Mirza N; Naumann A; Peter A; Löffler MW; Faul C; Vogel W; Bethge WA; Rammensee HG et al.
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

Allogeneic hematopoietic cell transplantation in patients ⩾70 years: which patients may benefit?

2016 | Journal article
Contributors: Haen SP; Pham M; Faul C; Dörfel D; Vogel W; Kanz L; Bethge WA
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

Graft versus self (GvS) against T-cell autoantigens is a mechanism of graft-host interaction.

2016-11 | Journal article
Contributors: Mirza N; Zierhut M; Korn A; Bornemann A; Vogel W; Schmid-Horch B; Bethge WA; Stevanović S; Salih HR; Kanz L et al.
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

An Fc-optimized CD133 antibody for induction of NK cell reactivity against myeloid leukemia.

2016-07 | Journal article
Contributors: Koerner SP; André MC; Leibold JS; Kousis PC; Kübler A; Pal M; Haen SP; Bühring HJ; Grosse-Hovest L; Jung G et al.
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

Soluble heat shock protein 70 members in patients undergoing allogeneic hematopoietic cell transplantation.

2016-05 | Journal article
Contributors: Mirza N; Prokop L; Kowalewski D; Gouttefangeas C; Faul C; Bethge WA; Vogel W; Kanz L; Rammensee HG; Haen SP
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

[Hematologic chest pain].

2016-04 | Journal article
Contributors: Haen SP; Mannal R; Steeg M; Seizer P; Rockenstiehl M; Mackensen-Haen S; Horger M; Kanz L; Vogel W
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

Prognostic relevance of HER2/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumab.

2016-03 | Journal article
Contributors: Haen SP; Schmiedel BJ; Rothfelder K; Schmied BJ; Dang TM; Mirza N; Möhle R; Kanz L; Vogel W; Salih HR
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

Choroidal metastases from thymic carcinoma during pregnancy: Case Report.

2015 | Journal article
Contributors: Haen SP; Stroebel P; Marx A; Suesskind D; Fend F; Reichmann U; Kopp HG; Kanz L; Mayer F
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.

2015-12 | Journal article
Contributors: Haen SP; Schumm M; Faul C; Kanz L; Bethge WA; Vogel W
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

The repertoire of human tumor-associated epitopes--identification and selection of antigens and their application in clinical trials.

2013-04 | Journal article
Contributors: Haen SP; Rammensee HG
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia.

2012-06 | Journal article
Contributors: Hofmann M; Große-Hovest L; Nübling T; Pyż E; Bamberg ML; Aulwurm S; Bühring HJ; Schwartz K; Haen SP; Schilbach K et al.
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

More than just tumor destruction: immunomodulation by thermal ablation of cancer.

2011 | Journal article
Contributors: Haen SP; Pereira PL; Salih HR; Rammensee HG; Gouttefangeas C
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation.

2011-09 | Journal article
Contributors: Haen SP; Gouttefangeas C; Schmidt D; Boss A; Clasen S; von Herbay A; Kosan B; Aebert H; Pereira PL; Rammensee HG
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation.

2011-06 | Journal article
Contributors: Widenmeyer M; Shebzukhov Y; Haen SP; Schmidt D; Clasen S; Boss A; Kuprash DV; Nedospasov SA; Stenzl A; Aebert H et al.
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

Particle size and activation threshold: a new dimension of danger signaling.

2010-06 | Journal article
Contributors: Rettig L; Haen SP; Bittermann AG; von Boehmer L; Curioni A; Krämer SD; Knuth A; Pascolo S
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

Fundus autofluorescence in multifocal choroiditis and panuveitis.

2008-05 | Journal article
Contributors: Haen SP; Spaide RF
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

The white dot syndromes.

2007 | Journal article
Contributors: Matsumoto Y; Haen SP; Spaide RF
Source: Self-asserted source
Sebastian Haen via Europe PubMed Central

Peer review (2 reviews for 2 publications/grants)

Review activity for Cell stress & chaperones. (1)
Review activity for Journal for immunotherapy of cancer. (1)